Share this with your colleagues!

New to this site?

Register Now

Existing site members

Forgot my password

2014 MAFP CME Conferences

  • Online CME Videocasts - Selected Topics from MD-AFP's CME Conferences
  • Clinical Topics Pertinent to Family Medicine and Primary Care
  • MD-AFP Members: Use for AAFP/MAFP CME requirements
  • Posted videos provide up to 7.75 total credits

Catalog Selections

All Presentations

June 2014 Annual CME Assembly

NEW

Buy all presentations here.

 

Presented by:

Raymond Cross, MD, MS, AGAF
Michael Miller, M.D.
Jeffrey Weinfeld, M.D.
Reid B. Blackwelder, M.D.
Bradley N. Gaynes, M.D., MPH
James P. Richardson, MD, MPH

 

Six comprehensive topics have been chosen from MAFP's June, 2014 Assembly Program to offer in this convenient online format. The topics are reviewed and are approved for .75 CME Credits each or up to a total of 4.75 CME Credits for all six. Credits from this program may be applied to both the AAFP and MAFP CME requirements.

 

Selected Topics:

  • Biologic Therapies in IBD
  • Clinical Practice Guidelines on Reducing Cardiovascular Risk
  • MU2, and ICD-10, and HIE Oh My! An Interactive IT Potpourri
  • Improving Adherence and Maintaining Remission in Major Depressive Disorder
  • Update in Geriatric Medicine: Approach to the Diagnosis and Treatment of Alzheimer's Disease
  • Update in Geriatric Medicine: Select Studies in Geriatric Medicine

@@@MoreBegin@@@

4.75 PD Credits
Member Price: $0.00
Non-member Price: $125.00
Presentation

Improving Adherence and Maintaining Remission in Major Depressive Disorder

Presented by: Bradley N. Gaynes, M.D., MPH

 

NEW

Need Statement 
Despite advances in depression management, the successful clinical resolution of depression in primary care settings is uncommon (Current Psychiatry Reports – 2012). It is critical that clinicians who care for patients with MDD be kept up to date on current evidence-based data and how to apply this information to the care of their patients. Successful, long-term management of patients with MDD involves use of existing treatments and new pharmacologic agents. Improving patient outcomes will require clinically focused educational programs that provide realistic treatment strategies based on the most current treatment data.


@@@MoreBegin@@@ Learning Objectives
At the end of this program, the learner will be able to:

1. Review the evidence base for managing depression in the acute phase of treatment
    a. Clarify why adherence is important
    b. Identify why remission is important
    c. Discuss measurement-based care (MBC)
2. Identify evidence-based strategies to improve patient adherence to treatment
3. Discuss strategy to maintain remission

1 PD Credits
Member Price: $0.00
Non-member Price: $25.00
Presentation

Update in Geriatric Medicine: Approach to the Diagnosis and Treatment of Alzheimers Disease

Presented by: James P. Richardson, MD, MPH

 

NEW

Need Statement 
Alzheimer’s disease (AD) is the most common form of dementia, yet it remains under diagnosed and under treated. As the world’s population continues to age, the number of patients with dementia will continue to grow. Family physicians and other primary care physicians are in a unique position to diagnose and treat these patients. Diagnosis of the typical patient with Alzheimer’s disease is straightforward in most instances. Treatment can slow down the progress of the disease and help the patient and his or her family better cope with this devastating problem.

@@@MoreBegin@@@ Learning Objectives
At the end of this program, the learner will be able to:

1. Know the risk factors for Alzheimer’s disease
2. Know how to diagnose Alzheimer’s disease
3. Know the pharmacologic and non-pharmacologic treatment of Alzheimer’s disease
4. Help families manage the patient with Alzheimer's disease

0.75 PD Credits
Member Price: $0.00
Non-member Price: $25.00
Presentation

MU2, and ICD-10, and HIE Oh My! An Interactive IT Potpourri

Presented by: Jeffrey Weinfeld, M.D.

 

NEW

Need Statement 
With the start of meaningful use Stage 2 and the deadline for ICD-10 implementation, 2014 will be an active year for health IT issues in family medicine. Providers need to understand the structure and requirements of these programs so that they can benefit from them and limit their potential negative impacts. Health information exchange can help providers get information about their patients and improve patient care. Through an interactive format, we will help family physicians understand the benefits and requirements of these programs, draw on the knowledge of attendees, and share experiences while helping each other avoid pitfalls.

@@@MoreBegin@@@ Learning Objectives
At the end of this program, the learner will be able to:

1. Describe the structure and requirements of the meaningful use program and identify recent updates.
2. Understand the basics of ICD-10 coding and identify your role in the implementation process for your practice.
3. List the benefits of participating in your regional health information exchange.

0.75 PD Credits
Member Price: $0.00
Non-member Price: $25.00
Presentation

Clinical Practice Guidelines on Reducing Cardiovascular Risk

Presented by: Michael Miller, M.D.

 

NEW


Need Statement
The ACC/AHA guidelines released in November 2013 place the focus for treating dyslipidemia into 4 groups based on risk of cardiovascular disease. Therapy has been streamlined to include statin therapy at moderate or high intensity. There are no longer LDL targets for therapy or the use of non-HDL as a secondary treatment strategy. The guidelines are designed based on the best clinical evidence available and may be modified as new clinical outcome data become available.

 

@@@MoreBegin@@@

Learning Objectives

At the end of this program, the learner will be able to:

1. Understand the rationale for the new AHA/ACC guidelines.

2. Know the indications for treatment of high cholesterol.

3. Summarize the side effect of statin therapy.

0.75 PD Credits
Member Price: $0.00
Non-member Price: $25.00
Presentation

Update in Geriatric Medicine: Select Studies in Geriatric Medicine

Presented by: Thomas Edmondson, M.D., A.G.S.F.

 

NEW

Need Statement 
Beyond the demographic imperative of the aging population in the U.S., our health care system is experiencing rapid changes in an attempt to provide efficient care for elderly patients across the continuum of care. In order to provide the right care at the right time in the right place, primary care providers are charged with acting as gate keeper and as the patient’s advocate. Adding to one’s database of knowledge for geriatric patients in the community, ALF, nursing home, and hospital presents new challenges in Maryland as the HSCRC restructures reimbursement to hospitals, thereby creating new pressures on patients’ primary care physicians.

@@@MoreBegin@@@ Learning Objectives
At the end of this program, the learner will be able to:

1. Review lessons learned from studies of geriatric patients across the continuum
2. Discuss some benefits of palliative medicine and when to provide palliative care
3. Understand the evidence underlying discussions of resuscitation and patients’ wishes

0.75 PD Credits
Member Price: $0.00
Non-member Price: $25.00
Presentation

Biologic Therapies in IBD

Presented by: Raymond Cross, MD, MS, AGAF

 

NEW

Need Statement 
1. Inflammatory bowel disease, comprised of Crohn’s disease and ulcerative colitis, are chronic, autoimmune conditions with a relapsing and remitting disease course. Over 1 million Americans are affected by the diseases.
2. Medical treatment is indicated for most patients to control symptoms, to prevent relapses of disease, and to prevent complications of disease.
3. Biologic therapy such as anti-TNF and anti-integrin agents are indicated for the treatment of moderate to severe inflammatory bowel disease refractory to conventional therapy.
4. Most patients tolerate biologic therapy well. However, adverse events such as infection, opportunistic infection, autoimmune reactions, and malignancy are more common in patients treated with biologic therapies.
5. Although effective for the treatment of inflammatory bowel diseases, there is controversy about the optimal timing of treatment, use of concurrent immune suppression, therapeutic monitoring, and duration of treatment.

@@@MoreBegin@@@ Learning Objectives
At the end of this program, the learner will be able to:

1. Identify the biologic agents used in the treatment of inflammatory bowel disease
2. Summarize the evidence supporting biologic therapies in inflammatory bowel disease
3. Identify the risks of treatment with biologic therapies in inflammatory bowel disease
4. Identify controversies in use of biologic therapies

0.75 PD Credits
Member Price: $0.00
Non-member Price: $25.00

Shopping Cart